Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

57P - Multidisciplinary brain metastasis clinic: Is it effective and worthwhile?


23 Nov 2019


Poster display session


Tumour Site

Central Nervous System Malignancies


Annu Rajpurohit


Annals of Oncology (2019) 30 (suppl_9): ix20-ix21. 10.1093/annonc/mdz419


A. Rajpurohit1, V.M. Patil1, V. Noronha1, A. Joshi1, N.S. Menon1, A. Puranik2, N. Purandare2, A. Mahajan3, N. Mummudi4, R. Krishnatry4, R. Kumar5, S. Yadav5, K. Prabhash1

Author affiliations

  • 1 Medical Oncology, Tata Memorial Hospital, 400012 - Mumbai/IN
  • 2 Nuclear Medicine, Tata Memorial Hospital, 400012 - Mumbai/IN
  • 3 Radiology, Tata Memorial Hospital, 400012 - Mumbai/IN
  • 4 Radiation Oncology, Tata Memorial Hospital, 400012 - Mumbai/IN
  • 5 Pathology, Tata Memorial Hospital, 400012 - Mumbai/IN


Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 57P


Management of brain metastasis is a complex multidisciplinary venture. Hence, we started a multidisciplinary brain metastasis clinic for opinion on difficult brain metastasis cases. This is the review of the impact of this clinic on the treatment decisions.


Brain metastasis clinic (BMC) was started in the month of April 2018 and meets once a week. Data of patients discussed between 27th April 2018 to 28th June 2019 were included for thisanalysis. Treatment decision made by clinicians (before sending the patient to the BMC were compared with the decisions made in BMC. The decisions were broken on a predefined proforma as intent of treatment (curative or palliative), modalities planned (surgery, radiation, chemotherapy), type of therapy planned (details of each therapy) in each modality were collected both pre and post BMC. In addition, compliance of the respective physicians to BMC decision was also calculated. SPSS version 20 was used for analysis. Descriptive statistics was performed.


Ninety-nine patients were discussed in this time period. The median age was 51 (range 17-68) years. The gender distribution was 70 males (70.7%) and 29 females (29.3%). Lung was thepredominant site of malignancy (79, 79.8%). Thirty-one patients (31.3%) had EGFR TKI domain activating mutation while 17 (17.2%) had ALK rearrangement. The treatment plan was changed in 46 patients (46.5%). The intent of treatment was changed in 5 patients (5.3%). Change in treatment plan with respect to surgery in 9 patients (9.1%), radiation in 37 patients (37.4%), chemotherapy in 15 patients (15.2%), targeted therapy in 11 patients (22.9%) and intrathecal in 6 patients (6.1%) respectively. The compliance to the BMC decision in patients in whom it was changed was 84.8% (39, n = 46).


Multidisciplinary management of difficult brain metastasis cases in specialized clinics has significant impact on treatment decisions.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

Tata Memorial Hospital, Mumbai.


Has not received any funding.


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.